Yayın: Synthesis and evaluation of naphthalene-based thiosemicarbazone derivatives as new anticancer agents against LNCaP prostate cancer cells
| dc.contributor.author | ALTINTOP, MEHLİKA DİLEK | |
| dc.contributor.author | KUŞ, GÖKHAN | |
| dc.contributor.author | SEVER, BELGİN | |
| dc.contributor.author | ÖZDEMİR, AHMET | |
| dc.contributor.author | KAPLANCIKLI, ZAFER ASIM | |
| dc.contributor.author | Selda Kabadere | |
| dc.contributor.author | Zafer Asım Kaplancıklı | |
| dc.contributor.orcid | 0000-0002-8159-663X | |
| dc.contributor.orcid | 0000-0003-4847-9711 | |
| dc.contributor.orcid | 0000-0003-0280-5550 | |
| dc.contributor.orcid | 0000-0002-2424-2720 | |
| dc.contributor.orcid | 0000-0002-9589-0063 | |
| dc.contributor.orcid | 0000-0003-2252-0923 | |
| dc.date.accessioned | 2025-11-13T10:08:24Z | |
| dc.date.issued | 2015-03-31 | |
| dc.identifier.doi | https://doi.org/10.3109/14756366.2015.1031126 | |
| dc.identifier.endpage | 7 | |
| dc.identifier.issn | 1475-6366 | |
| dc.identifier.issue | 3 | |
| dc.identifier.openalex | W2029127911 | |
| dc.identifier.startpage | 1 | |
| dc.identifier.uri | https://hdl.handle.net/11421/3243 | |
| dc.identifier.uri | https://doi.org/10.3109/14756366.2015.1031126 | |
| dc.identifier.volume | 31 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Journal of Enzyme Inhibition and Medicinal Chemistry | |
| dc.rights | openAccess | |
| dc.subject | LNCaP | |
| dc.subject | Apoptosis | |
| dc.subject | Chemistry | |
| dc.subject | Flow cytometry | |
| dc.subject | Prostate cancer | |
| dc.subject | MTT assay | |
| dc.subject | Cytotoxicity | |
| dc.subject | Cancer cell | |
| dc.subject | Cytotoxic T cell | |
| dc.subject | Semicarbazone | |
| dc.subject | Cancer research | |
| dc.subject | Pharmacology | |
| dc.subject | In vitro | |
| dc.subject | Cancer | |
| dc.subject | Stereochemistry | |
| dc.subject | Biochemistry | |
| dc.subject | Medicine | |
| dc.subject | Internal medicine | |
| dc.subject | Immunology | |
| dc.subject.sdg | 3 | |
| dc.title | Synthesis and evaluation of naphthalene-based thiosemicarbazone derivatives as new anticancer agents against LNCaP prostate cancer cells | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5048968214 | |
| local.authorid.openalex | A5001118647 | |
| local.authorid.openalex | A5040352588 | |
| local.authorid.openalex | A5100651829 | |
| local.authorid.openalex | A5060247565 |
